세계의 세포 용해 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품 유형별, 세포 유형별, 최종 사용자별, 지역별, 경쟁 시장별(2020-2030년)
Cell Lysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Product, By Type of cells, By End user, By Region and Competition, 2020-2030F
상품코드:1728131
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 세포 용해 시장은 2024년에 31억 6,000만 달러로 평가되었고, 2030년에는 48억 7,000만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 7.47%로 성장할 전망입니다.
이 시장은 제약, 생명공학, 의료 분야에서의 세포 기반의 연구 및 진단 용도 수요 증가에 의해 큰 성장을 이루고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
31억 6,000만 달러
시장 규모(2030년)
48억 7,000만 달러
CAGR(2025-2030년)
7.47%
급성장 부문
시약
최대 시장
북미
바이오 제약 산업의 확장과 표적 치료 및 개인 맞춤형 의약품으로의 전환으로 인해 단백질, DNA 및 RNA를 추출하기 위한 효율적인 세포 용해 기술에 대한 필요성이 강화되었습니다. 이와 동시에 유전체학 및 단백질체학의 발전으로 첨단 용해 기술의 도입이 가속화되고 있습니다. 연구자들이 다양한 세포 유형에서 생체 분자를 분리하는 데 집중하면서 정밀하고 확장 가능한 세포 용해 방법에 대한 수요는 계속 증가하고 있습니다. 이러한 응용 범위의 증가는 세포 용해가 치료제 개발과 분자 진단 모두에서 중요한 원동력이 되고 있습니다.
시장 성장 촉진요인
바이오 의약품의 발전
주요 시장 과제
세포 용해 장비 및 시약의 높은 비용
주요 시장 동향
생물학적 제제 및 개인 맞춤형 의약품에 대한 수요 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 세포 용해 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품 유형별(기기(균질기, 원심분리기, 기타 ), 시약)
세포 유형별(포유류 세포, 미생물 세포, 식물 세포)
최종 사용자별(생명공학 또는 바이오 의약품 기업, 연구 기관 및 학술 기관, 기타 최종 사용자)
기업별(2024년)
지역별
시장 맵
제6장 북미의 세포 용해 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 세포 용해 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 세포 용해 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 세포 용해 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 세포 용해 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
합병과 인수
제13장 PESTEL 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Danaher Corporation
Eppendorf AG
Hoffmann-La Roche Ltd
Labfreez Instruments Group Co. Ltd
Merck KGaA
Qsonica LLC
Takara Bio Inc.
Thermo Fisher Scientific Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
HBR
영문 목차
영문목차
The Global Cell Lysis Market was valued at USD 3.16 billion in 2024 and is projected to reach USD 4.87 billion by 2030, growing at a CAGR of 7.47% during the forecast period. This market is witnessing significant growth due to the increasing demand for cell-based research and diagnostic applications in the pharmaceutical, biotechnology, and healthcare sectors. Cell lysis-breaking open cells to access their internal components-is a foundational step in molecular biology, bioprocessing, and clinical diagnostics.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.16 Billion
Market Size 2030
USD 4.87 Billion
CAGR 2025-2030
7.47%
Fastest Growing Segment
Reagents
Largest Market
North America
The biopharmaceutical industry's expansion and the shift toward targeted therapies and personalized medicine have intensified the need for efficient cell lysis techniques to extract proteins, DNA, and RNA. In parallel, advancements in genomics and proteomics are accelerating the adoption of advanced lysis technologies. As researchers focus on biomolecular isolation from various cell types, the demand for precise and scalable cell lysis methods continues to grow. This rising application spectrum reinforces cell lysis as a critical enabler in both therapeutic development and molecular diagnostics.
Key Market Drivers
Biopharmaceutical Advancements
The accelerating growth of the biopharmaceutical industry is a central force driving the global cell lysis market. With increasing focus on biologics and personalized medicine, pharmaceutical companies rely on advanced cell lysis methods to extract therapeutic proteins, DNA, and RNA.
Cell lysis enhances the efficiency of drug development by facilitating rapid extraction and purification of target biomolecules. This is crucial for reducing time-to-market, especially during health crises where expedited drug development is vital. Biomanufacturing processes, including antibody and protein production, depend on optimized lysis techniques to increase yield and maintain product quality.
As the complexity of therapeutic molecules increases, advanced cell lysis tools help ensure high purity and minimize contamination, which is essential for patient safety and regulatory compliance. This growing reliance on cell lysis across the drug discovery and development lifecycle ensures sustained demand for high-performance lysis products and systems.
Key Market Challenges
High Cost of Cell Lysis Equipment and Reagents
A notable challenge in the global cell lysis market is the high cost associated with equipment and reagents. High-performance instruments, such as automated and high-pressure lysis systems, require significant capital investment, which can restrict access for smaller laboratories or institutions with limited funding.
Moreover, premium-grade reagents-including enzymes, detergents, and buffers-are necessary for specific applications but can be prohibitively expensive for routine use, especially in developing countries. This limits the adoption of advanced lysis solutions and contributes to disparities in research capabilities across different regions.
Budget constraints in academic or underfunded institutions further exacerbate this issue, potentially hindering innovations in therapeutic and diagnostic research where reliable lysis techniques are essential.
Key Market Trends
Rising Demand for Biologics and Personalized Medicine
A prominent trend shaping the cell lysis market is the increasing focus on biologics and personalized therapies. The development of complex biologics-such as monoclonal antibodies, gene therapies, and vaccines-requires efficient cell lysis processes for the extraction of high-quality biomolecules.
As personalized medicine gains traction, diagnostic labs are using cell lysis to isolate DNA, RNA, and proteins for genetic profiling and biomarker analysis. This enables clinicians to tailor treatments based on individual patient data, improving efficacy and minimizing side effects.
With the biopharmaceutical industry continuously innovating in molecular and precision medicine, cell lysis systems are evolving to support specific needs in both upstream and downstream processes, ensuring compatibility with high-throughput, scalable workflows.
Key Market Players
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Danaher Corporation
Eppendorf AG
Hoffmann-La Roche Ltd
Labfreez Instruments Group Co. Ltd
Merck KGaA
Qsonica LLC
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Report Scope:
In this report, the Global Cell Lysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cell Lysis Market, By Type of Product:
Instruments
Reagents
Cell Lysis Market, By Type of Cells:
Mammalian Cells
Microbial Cells
Plant Cells
Cell Lysis Market, By End User:
Biotechnology or Biopharmaceutical Companies
Research Laboratories and Academic Institutes
Other End Users
Cell Lysis Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Turkey
Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cell Lysis Market.
Available Customizations:
Global Cell Lysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cell Lysis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Product (Instruments {Homogeniser, Centrifugation, Other Types of Products}, Reagents)
5.2.2. By Type of cells (Mammalian Cells, Microbial Cells, Plant Cells)
5.2.3. By End user (Biotechnology or Biopharmaceutical Companies, Research Laboratories and Academic Institutes, Other End Users)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Cell Lysis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Product
6.2.2. By Type of cells
6.2.3. By End user
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Cell Lysis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Product
6.3.1.2.2. By Type of cells
6.3.1.2.3. By End user
6.3.2. Mexico Cell Lysis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Product
6.3.2.2.2. By Type of cells
6.3.2.2.3. By End user
6.3.3. Canada Cell Lysis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Product
6.3.3.2.2. By Type of cells
6.3.3.2.3. By End user
7. Europe Cell Lysis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Product
7.2.2. By Type of cells
7.2.3. By End user
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Cell Lysis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Product
7.3.1.2.2. By Type of cells
7.3.1.2.3. By End user
7.3.2. Germany Cell Lysis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Product
7.3.2.2.2. By Type of cells
7.3.2.2.3. By End user
7.3.3. United Kingdom Cell Lysis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Product
7.3.3.2.2. By Type of cells
7.3.3.2.3. By End user
7.3.4. Italy Cell Lysis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Product
7.3.4.2.2. By Type of cells
7.3.4.2.3. By End user
7.3.5. Spain Cell Lysis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Product
7.3.5.2.2. By Type of cells
7.3.5.2.3. By End user
8. Asia-Pacific Cell Lysis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Product
8.2.2. By Type of cells
8.2.3. By End user
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Cell Lysis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Product
8.3.1.2.2. By Type of cells
8.3.1.2.3. By End user
8.3.2. India Cell Lysis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Product
8.3.2.2.2. By Type of cells
8.3.2.2.3. By End user
8.3.3. South Korea Cell Lysis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Product
8.3.3.2.2. By Type of cells
8.3.3.2.3. By End user
8.3.4. Japan Cell Lysis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Product
8.3.4.2.2. By Type of cells
8.3.4.2.3. By End user
8.3.5. Australia Cell Lysis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Product
8.3.5.2.2. By Type of cells
8.3.5.2.3. By End user
9. South America Cell Lysis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Product
9.2.2. By Type of cells
9.2.3. By End user
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Cell Lysis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Product
9.3.1.2.2. By Type of cells
9.3.1.2.3. By End user
9.3.2. Argentina Cell Lysis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Product
9.3.2.2.2. By Type of cells
9.3.2.2.3. By End user
9.3.3. Colombia Cell Lysis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Product
9.3.3.2.2. By Type of cells
9.3.3.2.3. By End user
10. Middle East and Africa Cell Lysis Market Outlook